Free Trial

Pure Financial Advisors LLC Grows Position in Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Pure Financial Advisors LLC raised its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 57.1% during the first quarter, according to its most recent filing with the SEC. The firm owned 7,942 shares of the company's stock after purchasing an additional 2,886 shares during the period. Pure Financial Advisors LLC's holdings in Colgate-Palmolive were worth $744,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in CL. Omnia Family Wealth LLC increased its holdings in Colgate-Palmolive by 6.5% during the first quarter. Omnia Family Wealth LLC now owns 5,815 shares of the company's stock valued at $545,000 after buying an additional 356 shares during the period. Alpine Bank Wealth Management bought a new stake in Colgate-Palmolive during the 1st quarter valued at $7,906,000. Golden State Wealth Management LLC increased its holdings in shares of Colgate-Palmolive by 266.9% in the 1st quarter. Golden State Wealth Management LLC now owns 521 shares of the company's stock valued at $49,000 after acquiring an additional 379 shares during the period. Aurora Private Wealth Inc. raised its position in shares of Colgate-Palmolive by 49.7% in the 1st quarter. Aurora Private Wealth Inc. now owns 20,258 shares of the company's stock worth $1,898,000 after acquiring an additional 6,729 shares in the last quarter. Finally, MOKAN Wealth Management Inc. lifted its stake in shares of Colgate-Palmolive by 7.7% during the 1st quarter. MOKAN Wealth Management Inc. now owns 6,411 shares of the company's stock worth $601,000 after purchasing an additional 461 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Citigroup boosted their target price on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a report on Monday, April 28th. JPMorgan Chase & Co. boosted their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research note on Monday, April 28th. Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. UBS Group lifted their price target on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. Finally, Piper Sandler decreased their price objective on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a report on Monday, March 31st. One analyst has rated the stock with a sell rating, ten have given a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $101.69.

View Our Latest Report on CL

Colgate-Palmolive Trading Up 0.1%

Colgate-Palmolive stock opened at $87.85 on Friday. The stock has a 50-day moving average price of $90.99 and a 200 day moving average price of $90.64. The company has a market capitalization of $71.19 billion, a price-to-earnings ratio of 24.82, a price-to-earnings-growth ratio of 4.66 and a beta of 0.38. Colgate-Palmolive Company has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.92 billion. During the same period in the prior year, the firm earned $0.86 EPS. The business's revenue for the quarter was down 3.0% on a year-over-year basis. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.37%. Colgate-Palmolive's payout ratio is currently 58.76%.

Colgate-Palmolive announced that its board has approved a stock repurchase program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double
The Next Palantir? AI-Defense Stock Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines